A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis

Grants and Contracts Details

StatusFinished
Effective start/end date10/30/153/25/21

Funding

  • Quintiles Inc: $83,043.00